Table 1.
Assaya | Muscle mitochondria | Fibroblast homogenate | ||
---|---|---|---|---|
Patient | Controls ± SD (range) n = 50 | Patient | Control mean n = 4 | |
CI | 106 [98%] | 98 ± 46 (46–215) | nd | nd |
CI + III | 159 [65%] | 305 ± 148 (104–717) | nd | nd |
CII | 141 [116%] | 124 ± 57 (52–230) | nd | nd |
CII + III | 75 [105%] | 80 ± 40 (41–172) | nd | nd |
CIV | 209 [25%] | 1,061 ± 47 (265–2,896) | 61 [115%] | 72 ± 22 (62–135) |
CS | 980 | 1,132 ± 438 (438–2,350) | 42 | 45 ± 12 (30–66) |
nd not determined
anmol/min/mg (%) percentage residual activity normalized to citrate synthase (CS) activity compared to controls